{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T07:54:16Z","timestamp":1791273256815,"version":"4.1.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T00:00:00Z","timestamp":1759190400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T00:00:00Z","timestamp":1759190400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-04432-3","type":"journal-article","created":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T13:35:58Z","timestamp":1759239358000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Lapachol interferes with the cell cycle and inhibits proliferation and migration of bladder tumor cells with effects on ncRNA expression"],"prefix":"10.1038","volume":"15","author":[{"given":"Tatiane Roquete","family":"Amparo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamila de F\u00e1tima","family":"da Anuncia\u00e7\u00e3o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamires Cunha","family":"Almeida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ala\u00edde Braga","family":"de Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glenda Nicioli","family":"da Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geraldo C\u00e9lio","family":"Brand\u00e3o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,30]]},"reference":[{"key":"4432_CR1","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung, H. et al. Global cancer statistics 2020: GLOBOCAN Estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 71, 209\u2013249 (2021).","journal-title":"CA Cancer J. Clin."},{"key":"4432_CR2","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1093\/glycob\/cwab083","volume":"31","author":"B Ezeabikwa","year":"2021","unstructured":"Ezeabikwa, B. et al. Major differences in glycosylation and fucosyltransferase expression in low-grade versus high-grade bladder cancer cell lines. Glycobiology 31, 1444\u20131463 (2021).","journal-title":"Glycobiology"},{"key":"4432_CR3","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.jare.2021.11.010","volume":"39","author":"S Liu","year":"2022","unstructured":"Liu, S., Chen, X. & Lin, T. Emerging strategies for the improvement of chemotherapy in bladder cancer: Current knowledge and future perspectives. J. Adv. Res. 39, 187\u2013202 (2022).","journal-title":"J. Adv. Res."},{"key":"4432_CR4","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1007\/s10147-008-0815-x","volume":"13","author":"H Nishiyama","year":"2008","unstructured":"Nishiyama, H., Watanabe, J. & Ogawa, O. p53 and chemosensitivity in bladder cancer. Int. J. Clin. Oncol. 13, 282\u2013286 (2008).","journal-title":"Int. J. Clin. Oncol."},{"key":"4432_CR5","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.canlet.2016.08.015","volume":"382","author":"J Pan","year":"2016","unstructured":"Pan, J. et al. Long non-coding RNA UCA1 promotes cisplatin\/gemcitabine resistance through CREB modulating miR-196a-5p in bladder cancer cells. Cancer Lett. 382, 64\u201376 (2016).","journal-title":"Cancer Lett."},{"key":"4432_CR6","doi-asserted-by":"publisher","first-page":"e8261","DOI":"10.7717\/peerj.8261","volume":"7","author":"G Wu","year":"2019","unstructured":"Wu, G. et al. Significance of TP53 mutation in bladder cancer disease progression and drug selection. PeerJ 7, e8261. https:\/\/doi.org\/10.7717\/peerj.8261 (2019).","journal-title":"PeerJ"},{"key":"4432_CR7","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1038\/s41580-022-00566-8","volume":"24","author":"JS Mattick","year":"2023","unstructured":"Mattick, J. S. et al. Long non-coding RNAs: Definitions, functions, challenges and recommendations. Nat. Rev. Mol. Cell Biol. 24, 430\u2013447 (2023).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"4432_CR8","doi-asserted-by":"publisher","first-page":"495","DOI":"10.2147\/OTT.S183940","volume":"12","author":"J Wu","year":"2019","unstructured":"Wu, J. et al. Long noncoding RNA UCA1 targets miR-582-5p and contributes to the progression and drug resistance of bladder cancer cells through ATG7-mediated autophagy inhibition. Onco. Targets Ther. 12, 495\u2013508 (2019).","journal-title":"Onco. Targets Ther."},{"key":"4432_CR9","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/s12894-023-01292-9","volume":"23","author":"S Zhu","year":"2023","unstructured":"Zhu, S., Li, H., Fan, Y. & Tang, C. Comprehensive analysis of cuproptosis-related lncRNAs signature to predict prognosis in bladder urothelial carcinoma. BMC Urol. 23, 124. https:\/\/doi.org\/10.1186\/s12894-023-01292-9 (2023).","journal-title":"BMC Urol."},{"key":"4432_CR10","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.mrfmmm.2014.02.006","volume":"762","author":"AL Savio","year":"2014","unstructured":"Savio, A. L., Silva, G. N., Camargo, E. A. & Salvadori, D. M. Cell cycle kinetics, apoptosis rates, DNA damage and TP53 gene expression in bladder cancer cells treated with allyl isothiocyanate (mustard essential oil). Mutat. Res. 762, 40\u201346 (2014).","journal-title":"Mutat. Res."},{"key":"4432_CR11","doi-asserted-by":"publisher","first-page":"3838","DOI":"10.1080\/14786419.2022.2151007","volume":"37","author":"TC Almeida","year":"2023","unstructured":"Almeida, T. C., Melo, A. S., Lima, A. P. B., Branquinho, R. T. & Silva, G. N. Resveratrol induces the production of reactive oxygen species, interferes with the cell cycle, and inhibits the cell migration of bladder tumour cells with different TP53 status. Nat. Prod. Res. 37, 3838\u20133843 (2023).","journal-title":"Nat. Prod. Res."},{"key":"4432_CR12","doi-asserted-by":"publisher","first-page":"103046","DOI":"10.1016\/j.arabjc.2021.103046","volume":"14","author":"SS El-Hawary","year":"2021","unstructured":"El-Hawary, S. S., Taher, M. A., Amin, E., AbouZid, S. F. & Mohammed, R. Genus Tabebuia: A comprehensive review journey from past achievements to future perspectives. Arabian J. Chem. 14, 103046. https:\/\/doi.org\/10.1016\/j.arabjc.2021.103046 (2021).","journal-title":"Arabian J. Chem."},{"key":"4432_CR13","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s11101-013-9289-1","volume":"13","author":"F Epifano","year":"2014","unstructured":"Epifano, F., Genovese, S., Fiorito, S., Mathieu, V. & Kiss, R. Lapachol and its congeners as anticancer agents: A review. Phytochem. Rev. 13, 37\u201349 (2014).","journal-title":"Phytochem. Rev."},{"key":"4432_CR14","doi-asserted-by":"publisher","first-page":"620","DOI":"10.2174\/1874467213666201005122230","volume":"14","author":"J Kim","year":"2021","unstructured":"Kim, J. & Kim, M. M. Effect of lapachol on the inhibition of matrix metalloproteinase related to the invasion of human fibrosarcoma cells. Curr. Mol. Pharmacol. 14, 620\u2013626 (2021).","journal-title":"Curr. Mol. Pharmacol."},{"key":"4432_CR15","doi-asserted-by":"publisher","first-page":"110936","DOI":"10.1016\/j.biopha.2020.110936","volume":"133","author":"SEM Miranda","year":"2021","unstructured":"Miranda, S. E. M. et al. Enhanced antitumor efficacy of lapachol-loaded nanoemulsion in breast cancer tumor model. Biomed. Pharmacother. 133, 110936. https:\/\/doi.org\/10.1016\/j.biopha.2020.110936 (2021).","journal-title":"Biomed. Pharmacother."},{"key":"4432_CR16","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.ejmech.2017.12.051","volume":"145","author":"GC Brand\u00e3o","year":"2018","unstructured":"Brand\u00e3o, G. C. et al. Antimalarial naphthoquinones. Synthesis via click chemistry, in vitro activity, docking to PfDHODH and SAR of lapachol-based compounds. Eur. J. Med. Chem. 145, 191\u2013205 (2018).","journal-title":"Eur. J. Med. Chem."},{"key":"4432_CR17","doi-asserted-by":"publisher","first-page":"2258","DOI":"10.1038\/s41598-024-51881-3","volume":"14","author":"LBA Vaz","year":"2024","unstructured":"Vaz, L. B. A. et al. Identification, characterization and quantification of xanthones from Fridericia formosa leaves extract with antiviral activity. Sci. Rep. 14, 2258. https:\/\/doi.org\/10.1038\/s41598-024-51881-3 (2024).","journal-title":"Sci. Rep."},{"key":"4432_CR18","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1093\/mutage\/geaa021","volume":"2020","author":"APB Lima","year":"2020","unstructured":"Lima, A. P. B. et al. Toxicogenetic and antiproliferative effects of chrysin in urinary bladder cancer cells. Mutagenesis 2020, 361. https:\/\/doi.org\/10.1093\/mutage\/geaa021 (2020).","journal-title":"Mutagenesis"},{"key":"4432_CR19","doi-asserted-by":"publisher","first-page":"e20230265","DOI":"10.1590\/1678-4685-gmb-2023-0265","volume":"47","author":"GND Silva","year":"2024","unstructured":"Silva, G. N. D. et al. Combined expression of JHDM1D\/KDM7A gene and long non-coding RNA RP11\u2013363E7.4 as a biomarker for urothelial cancer prognosis. Genet. Mol. Biol. 47, e20230265. https:\/\/doi.org\/10.1590\/1678-4685-gmb-2023-0265 (2024).","journal-title":"Genet. Mol. Biol."},{"key":"4432_CR20","doi-asserted-by":"publisher","first-page":"5245","DOI":"10.1158\/0008-5472.CAN-04-0496","volume":"64","author":"CL Andersen","year":"2004","unstructured":"Andersen, C. L., Jensen, J. L. & \u00d8rntoft, T. F. Normalization of real-time quantitative reverse transcription-PCR data: A model-based variance estimation approach to identify genes suited for normalization, applied to bladder and colon cancer data sets. Cancer Res. 64, 5245\u20135250 (2004).","journal-title":"Cancer Res."},{"key":"4432_CR21","doi-asserted-by":"publisher","first-page":"8367","DOI":"10.3390\/molecules27238367","volume":"27","author":"A Naeem","year":"2022","unstructured":"Naeem, A. et al. Natural products as anticancer agents: Current status and future perspectives. Molecules 27, 8367. https:\/\/doi.org\/10.3390\/molecules27238367 (2022).","journal-title":"Molecules"},{"key":"4432_CR22","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.2174\/1389557521666211101161548","volume":"22","author":"TC Almeida","year":"2022","unstructured":"Almeida, T. C. Modulation of long non-coding RNAs by different classes of secondary metabolites from plants: A mini-review on antitumor effects. Mini Rev. Med. Chem. 22, 1232\u20131255 (2022).","journal-title":"Mini Rev. Med. Chem."},{"key":"4432_CR23","doi-asserted-by":"publisher","first-page":"154166","DOI":"10.1016\/j.prp.2022.154166","volume":"239","author":"TC Almeida","year":"2022","unstructured":"Almeida, T. C. Modulation of non-coding RNAs by natural compounds as a potential therapeutical approach in oral cancer: A comprehensive review. Pathol. Res. Pract. 239, 154166. https:\/\/doi.org\/10.1016\/j.prp.2022.154166 (2022).","journal-title":"Pathol. Res. Pract."},{"key":"4432_CR24","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1186\/s12885-023-10828-z","volume":"23","author":"P Hui","year":"2023","unstructured":"Hui, P., Ni, F., Zheng, L., Jia, L. & Wang, Z. Identification of immunotherapy-related lncRNA signature for predicting prognosis, immunotherapy responses and drug candidates in bladder cancer. BMC Cancer 23, 355. https:\/\/doi.org\/10.1186\/s12885-023-10828-z (2023).","journal-title":"BMC Cancer"},{"key":"4432_CR25","doi-asserted-by":"publisher","first-page":"2412","DOI":"10.3390\/molecules28052412","volume":"28","author":"IOA Pereira","year":"2023","unstructured":"Pereira, I. O. A. LncRNA JHDM1D-AS1 Is a key biomarker for progression and modulation of gemcitabine sensitivity in bladder cancer cells. Molecules 28, 2412. https:\/\/doi.org\/10.3390\/molecules28052412 (2023).","journal-title":"Molecules"},{"key":"4432_CR26","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.2174\/1381612828666220418131506","volume":"28","author":"F Tan","year":"2022","unstructured":"Tan, F. et al. LncRNA SBF2-AS1: A budding star in various cancers. Curr. Pharm. Des. 28, 1513\u20131522 (2022).","journal-title":"Curr. Pharm. Des."},{"key":"4432_CR27","doi-asserted-by":"publisher","first-page":"149061","DOI":"10.1016\/j.gene.2024.149061","volume":"935","author":"EA Oliveira","year":"2024","unstructured":"Oliveira, E. A., Almeida, T. C. & Silva, G. N. Oncogenic role of lncRNA SBF2-AS1 in bladder cancer. Gene 935, 149061. https:\/\/doi.org\/10.1016\/j.gene.2024.149061 (2024).","journal-title":"Gene"},{"key":"4432_CR28","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1002\/tox.22555","volume":"33","author":"CT Chen","year":"2018","unstructured":"Chen, C. T. et al. Glabridin induces apoptosis and cell cycle arrest in oral cancer cells through the JNK1\/2 signaling pathway. Environ. Toxicol. 33, 679\u2013685 (2018).","journal-title":"Environ. Toxicol."},{"key":"4432_CR29","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1002\/cbf.3514","volume":"38","author":"C Chen","year":"2020","unstructured":"Chen, C. et al. Overexpression of long non-coding RNA RP11-363E7.4 inhibits proliferation and invasion in gastric cancer. Cell. Biochem. Funct. 38, 921\u2013931 (2020).","journal-title":"Cell. Biochem. Funct."},{"key":"4432_CR30","doi-asserted-by":"publisher","first-page":"115799","DOI":"10.1016\/j.bcp.2023.115799","volume":"216","author":"CY Li","year":"2023","unstructured":"Li, C. Y. et al. Lysine-specific demethylase 7A (KDM7A): A potential target for disease therapy. Biochem. Pharmacol. 216, 115799. https:\/\/doi.org\/10.1016\/j.bcp.2023.115799 (2023).","journal-title":"Biochem. Pharmacol."},{"key":"4432_CR31","doi-asserted-by":"publisher","first-page":"5658","DOI":"10.3390\/ijms21165658","volume":"21","author":"KH Lee","year":"2020","unstructured":"Lee, K. H. et al. Histone demethylase KDM7A regulates androgen receptor activity, and its chemical inhibitor TC-E 5002 overcomes cisplatin-resistance in bladder cancer cells. Int. J. Mol. Sci. 21, 5658. https:\/\/doi.org\/10.3390\/ijms21165658 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"4432_CR32","first-page":"21","volume":"110","author":"A Munshi","year":"2005","unstructured":"Munshi, A., Hobbs, M. & Meyn, R. E. Clonogenic cell survival assay. Methods Mol. Med. 110, 21\u201328 (2005).","journal-title":"Methods Mol. Med."},{"key":"4432_CR33","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/978-1-0716-1205-7_4","volume":"2265","author":"JT Freitas","year":"2021","unstructured":"Freitas, J. T., Jozic, I. & Bedogni, B. Wound healing assay for melanoma cell migration. Methods Mol. Biol. 2265, 65\u201371 (2021).","journal-title":"Methods Mol. Biol."},{"key":"4432_CR34","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1083\/jcb.201009059","volume":"192","author":"PA Muller","year":"2011","unstructured":"Muller, P. A., Vousden, K. H. & Norman, J. C. p53 and its mutants in tumor cell migration and invasion. J. Cell Biol. 192, 209\u2013218 (2011).","journal-title":"J. Cell Biol."},{"key":"4432_CR35","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1186\/s13046-016-0455-3","volume":"35","author":"H Xu","year":"2016","unstructured":"Xu, H. et al. Inhibitory effects of lapachol on rat C6 glioma in vitro and in vivo by targeting DNA topoisomerase I and topoisomerase II. J. Exp. Clin. Cancer Res. 35, 178. https:\/\/doi.org\/10.1186\/s13046-016-0455-3 (2016).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"4432_CR36","doi-asserted-by":"publisher","first-page":"e0191419","DOI":"10.1371\/journal.pone.0191419","volume":"13","author":"MS Babu","year":"2018","unstructured":"Babu, M. S. et al. Lapachol inhibits glycolysis in cancer cells by targeting pyruvate kinase M2. PLoS ONE 13, e0191419. https:\/\/doi.org\/10.1371\/journal.pone.0191419 (2018).","journal-title":"PLoS ONE"},{"key":"4432_CR37","doi-asserted-by":"publisher","first-page":"348","DOI":"10.20892\/j.issn.2095-3941.2017.0033","volume":"14","author":"J Bai","year":"2017","unstructured":"Bai, J., Li, Y. & Zhang, G. Cell cycle regulation and anticancer drug discovery. Cancer Biol Med. 14, 348\u2013362 (2017).","journal-title":"Cancer Biol Med."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-04432-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-04432-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-04432-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T13:35:59Z","timestamp":1759239359000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-04432-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,30]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4432"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-04432-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,30]]},"assertion":[{"value":"23 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}}],"article-number":"33829"}}